Table 2.
All-cause case fatality following COVID-19 by tumour subtype (ICD-10 codes), before and after age and sex correction
| Deaths (n) | Case–fatality rate | Univariable OR (95% CI) | p value | Multivariable adjusted OR (95% CI) | p value | |
|---|---|---|---|---|---|---|
| Prostate (C61) | 49 | 0·43 | 2·14 (1·17–3·96) | 0·014 | 1·09 (0·51–2·33) | 0·82 |
| Lung (C34) | 43 | 0·387 | 1·62 (0·89–3·00) | 0·118 | 1·41 (0·75–2·67) | 0·29 |
| Mesothelial and soft tissue (C45–C49) | 6 | 0·375 | 1·18 (0·37–3·51) | 0·772 | 1·52 (0·43–5·30) | 0·51 |
| Urinary tract (C64–C68) | 23 | 0·299 | 1·08 (0·54–2·13) | 0·834 | 0·87 (0·41–1·81) | 0·72 |
| Colorectal (C18–C21) | 35 | 0·282 | 1·03 (0·56–1·90) | 0·934 | 0·85 (0·44–1·64) | 0·63 |
| CNS (C69–C72) | 7 | 0·28 | 1·15 (0·39–3·18) | 0·797 | 1·87 (0·57–6·05) | 0·29 |
| Respiratory organs and intrathoracic organs (not lung; C30–C39) | 3 | 0·273 | 0·84 (0·17–3·29) | 0·813 | 0·96 (0·18–4·10) | 0·95 |
| Lip, oral cavity, and pharynx (C00–C14) | 8 | 0·242 | 0·75 (0·28–1·85) | 0·542 | 0·77 (0·25–2·27) | 0·64 |
| Breast (C50) | 26 | 0·182 | 0·53 (0·28–1·00) | 0·049 | 0·97 (0·40–2·52) | 0·94 |
| Female genital organs (C51–C58) | 7 | 0·125 | 0·36 (0·13–0·87) | 0·031 | 0·79 (0·24–2·63) | 0·70 |
| Myeloma (C90) | 16 | 0·432 | 1·85 (0·81–4·22) | 0·142 | 1·65 (0·71–3·85) | 0·24 |
| Leukaemia (C91–C95) | 33 | 0·418 | 2·03 (1·04–3·97) | 0·038 | 2·25 (1·13–4·57) | 0·023 |
| Lymphoma (C81–C85) | 25 | 0·316 | 1·60 (0·80–3·19) | 0·184 | 1·72 (0·81–3·68) | 0·16 |
| Other haematological (C86, C88, C96) | 7 | 0·241 | 0·81 (0·28–2·12) | 0·675 | 0·81 (0·26–2·33) | 0·70 |
| Digestive organs, non-colorectal (C15–C17, C22–C26) | 28 | 0·295 | 1 (ref) | .. | 1 (ref) | .. |
OR=odds ratio. ICD-10=International Classification of Diseases, 10th Revision. OR was calculated with digestive organs (non-colorectal; ICD-10 codes C15–C17, C22–C26) as a reference. Multivariable corrections were done, correcting for patient age and sex.